The Interface between Immunotransfusion and Hemostasis and Thrombosis Testing.

about

Rare forms of von Willebrand disease

P2860

Q57300553-A52CB2B8-211E-425D-B8F4-BF87879C82A2

P2860

The Interface between Immunotransfusion and Hemostasis and Thrombosis Testing.

Item

http://www.wikidata.org/entity/Q50200375

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

The Interface between Immunotransfusion and Hemostasis and Thrombosis Testing.

@en

The Interface between Immunotransfusion and Hemostasis and Thrombosis Testing.

@nl

type

Item

label

The Interface between Immunotransfusion and Hemostasis and Thrombosis Testing.

@en

The Interface between Immunotransfusion and Hemostasis and Thrombosis Testing.

@nl

prefLabel

The Interface between Immunotransfusion and Hemostasis and Thrombosis Testing.

@en

The Interface between Immunotransfusion and Hemostasis and Thrombosis Testing.

@nl

P1476

The Interface between Immunotransfusion and Hemostasis and Thrombosis Testing.

@en

P2860

Management of bleeding and coagulopathy following major trauma: an updated European guideline.

Red blood cell transfusion for people undergoing hip fracture surgery

Thromboelastography (TEG) and rotational thromboelastometry (ROTEM) for trauma-induced coagulopathy in adult trauma patients with bleeding

Transfusion thresholds and other strategies for guiding allogeneic red blood cell transfusion

Serious Hazards of Transfusion (SHOT) haemovigilance and progress is improving transfusion safety

Platelet-erythrocyte interactions enhance alpha(IIb)beta(3) integrin receptor activation and P-selectin expression during platelet recruitment: down-regulation by aspirin ex vivo

Large-scale association analysis identifies 13 new susceptibility loci for coronary artery disease.

Platelet transfusions in platelet consumptive disorders are associated with arterial thrombosis and in-hospital mortality.

The relationship between blood groups and disease.

Non-O blood type is the commonest genetic risk factor for VTE: results from a meta-analysis of the literature.

P304

43-56

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/978-1-4939-7196-1_3

http://www.w3.org/2001/XMLSchema#string

P407

English

P478

1646

http://www.w3.org/2001/XMLSchema#string

P50

Massimo Franchini

P577

2017-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28804817

http://www.w3.org/2001/XMLSchema#string

P921

thrombosis

The Interface between Immunotransfusion and Hemostasis and Thrombosis Testing.

about

P2860

P2860

The Interface between Immunotransfusion and Hemostasis and Thrombosis Testing.

description

name

type

label

prefLabel

P1433

P1476

P2860

P304

P31

P356

P407

P478

P50

P577

P698

P921

P356

P1433

P1476

P2860

P304

P31

P356

P407

P478

P50

P577

P698

P921